GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,509,000 | -5.7% | 39,502 | -0.6% | 1.44% | +15.1% |
Q2 2018 | $1,601,000 | -2.6% | 39,727 | -5.6% | 1.25% | -5.6% |
Q1 2018 | $1,644,000 | +9.7% | 42,077 | -0.4% | 1.33% | +9.0% |
Q4 2017 | $1,498,000 | -12.6% | 42,229 | 0.0% | 1.22% | -12.1% |
Q3 2017 | $1,714,000 | -6.5% | 42,229 | -0.7% | 1.39% | -12.1% |
Q2 2017 | $1,834,000 | +2.3% | 42,529 | 0.0% | 1.58% | +13.4% |
Q1 2017 | $1,793,000 | +9.5% | 42,529 | 0.0% | 1.39% | +5.7% |
Q4 2016 | $1,638,000 | -10.7% | 42,529 | 0.0% | 1.32% | -10.8% |
Q3 2016 | $1,834,000 | +6.3% | 42,529 | +6.9% | 1.48% | +4.3% |
Q2 2016 | $1,725,000 | +7.4% | 39,800 | +0.5% | 1.41% | +1.5% |
Q1 2016 | $1,606,000 | +0.5% | 39,600 | 0.0% | 1.39% | -1.1% |
Q4 2015 | $1,598,000 | +2.2% | 39,600 | -2.6% | 1.41% | -4.0% |
Q3 2015 | $1,563,000 | -6.2% | 40,656 | +1.6% | 1.47% | +5.0% |
Q2 2015 | $1,667,000 | -10.0% | 40,031 | -0.2% | 1.40% | -11.9% |
Q1 2015 | $1,852,000 | +6.9% | 40,131 | -1.0% | 1.58% | +6.0% |
Q4 2014 | $1,732,000 | – | 40,531 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |